Chloroquine treatment will be decided between patient and doctor. The Ministry of Health has issued new guidelines on the use of chloroquine and hydroxychloroquine for the treatment of Covid-19. The new guidelines are for the early use of the drug, when the patient has mild or moderate symptoms of the disease.
The prescription, in these cases, must be at the discretion of the doctor, in addition to the need for a declaration from the patient or family members for the use of the medication. The protocol starts to be valid for all patients diagnosed with the new coronavirus being treated in the public health network. The government has already distributed 2.9 million units of chloroquine phosphate throughout the country.
In his social networks, the President of the Republic, Jair Bolsonaro, explained that chloroquine can be used in mild cases, with medical recommendation and authorization from the patient / family. “There is still no scientific evidence, but it is being monitored and used in Brazil and worldwide. However, we are at war: ‘Worse than being defeated is the shame of not having fought’. ”
According to the Ministry of Health, the new orientation of the Federal Government wants to guarantee equal rights between patients in the public and private health systems. “There is a clamor from society, through medical institutions, popular and parliamentary representations, asking the Ministry of Health for a formal manifestation, since in Brazil, for Brazilians of a certain social class, there is the right to prescribe these drugs; and for a less economically favored layer, there is a limitation of access to these medications ”, said the secretary of Labor Management and Health Education, Mayra Pinheiro.
“What we want today is to make the principle of equity defended and guaranteed by SUS as a reality for all Brazilians,” he said.
According to the Ministry of Health, states, municipalities and private hospitals have already established their own protocols for the use of chloroquine and hydroxychloroquine. He said that there are studies on the drug, but that, to date, there is no robust scientific evidence to enable the indication of therapy. But he indicated that the new guidance standardizes the information for SUS health professionals and that it will be up to the doctor to decide to prescribe the medicine with the patient’s approval. “We are not moving away from science, we are approaching the need to guarantee life in times of war,” said the secretary.
“We are careful, attentive and doing our part so that all efforts in Brazil happen to reduce deaths, reduce the suffering of families and guarantee timely and early access to the only treatment we have today for this disease”, he said.
For severe cases, the previous protocol continues, in which the use of chloroquine and hydroxychloroquine was already authorized in the treatment of patients.
Symptoms of Covid-19
– loss of smell and / or taste
– headache, muscle or abdominal pain
– persistent cough with persistent daily fever
– persistent cough with progressive worsening of another symptom related to Covid-19
– at least one of the above symptoms + presence of a risk factor (elderly; patients with chronic diseases, including diabetes, hypertension and asthma; pregnant and lactating women)
– Severe Acute Respiratory Syndrome
– Flu syndrome that presents: Dyspnea / respiratory distress
– persistent chest pressure
– O2 saturation less than 95% in ambient air
– bluish coloring of lips or face